PELLEGRINI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.800
AS - Asia 1.939
EU - Europa 1.744
SA - Sud America 357
AF - Africa 32
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.881
Nazione #
US - Stati Uniti d'America 3.729
SG - Singapore 930
IE - Irlanda 497
CN - Cina 427
BR - Brasile 315
DE - Germania 244
HK - Hong Kong 206
RU - Federazione Russa 191
IT - Italia 170
SE - Svezia 156
TR - Turchia 139
GB - Regno Unito 116
UA - Ucraina 102
VN - Vietnam 95
FI - Finlandia 89
FR - Francia 45
CA - Canada 41
IN - India 30
JP - Giappone 27
CZ - Repubblica Ceca 26
PL - Polonia 24
MX - Messico 21
ES - Italia 20
AR - Argentina 17
BE - Belgio 17
NL - Olanda 15
KR - Corea 11
BD - Bangladesh 10
LT - Lituania 10
ZA - Sudafrica 10
ID - Indonesia 9
IQ - Iraq 9
JO - Giordania 7
VE - Venezuela 7
MA - Marocco 5
PE - Perù 5
AU - Australia 4
GE - Georgia 4
HN - Honduras 4
IL - Israele 4
KZ - Kazakistan 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CO - Colombia 3
EU - Europa 3
IR - Iran 3
KE - Kenya 3
PK - Pakistan 3
TN - Tunisia 3
AO - Angola 2
AT - Austria 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
MY - Malesia 2
PY - Paraguay 2
SN - Senegal 2
SR - Suriname 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 7.881
Città #
Dallas 822
Chandler 533
Dublin 497
Singapore 483
Jacksonville 382
Ashburn 223
Hong Kong 202
Santa Clara 183
Boardman 160
New York 110
Izmir 74
Nanjing 71
Lawrence 66
Princeton 66
Munich 65
Wilmington 65
Beijing 64
Ann Arbor 63
Los Angeles 61
The Dalles 60
Moscow 59
San Mateo 42
São Paulo 39
Columbus 38
L'aquila 33
Ho Chi Minh City 32
Seattle 30
Hefei 29
Nanchang 29
Helsinki 27
Warsaw 24
Woodbridge 24
L’Aquila 23
Tokyo 23
Turku 23
Bremen 22
Brno 21
Hanoi 18
Brussels 17
Denver 17
Montreal 17
Tianjin 17
Dearborn 16
Des Moines 16
Falkenstein 16
Stockholm 16
London 15
Houston 14
Rio de Janeiro 14
Verona 14
Atlanta 13
Poplar 13
Rome 13
Brooklyn 12
Council Bluffs 12
Falls Church 12
Milan 12
Shenyang 12
Chicago 11
Dong Ket 11
Ankara 10
Boston 10
Hebei 10
Kunming 10
Mountain View 10
San Jose 10
Seoul 10
Amsterdam 9
Jiaxing 9
Lappeenranta 9
Ningbo 9
Phoenix 9
San Francisco 9
Zhengzhou 9
Berlin 8
Frankfurt am Main 8
Guangzhou 8
Johannesburg 8
Mexico City 8
Belo Horizonte 7
Campinas 7
Jakarta 7
Jinan 7
Orem 7
Porto Alegre 7
Salvador 7
Shanghai 7
Amman 6
Aquila 6
Baghdad 6
Changsha 6
Manchester 6
Mumbai 6
Norwalk 6
Philadelphia 6
Pune 6
Toronto 6
Brasília 5
Chennai 5
Nancy 5
Totale 5.400
Nome #
Pyrroloquinoline Quinone (PQQ) Attenuates Hydrogen Peroxide-Induced Injury Through the Enhancement of Mitochondrial Function in Human Trabecular Meshwork Cells 345
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 158
MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study 148
Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location 144
Replacement R164H and V240H by site-directed mutagenesis of TEM-149 ESBL: kinetic analysis of TEM-149H240 and TEM-149H164-H240 laboratory mutants 136
Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma? 132
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals 131
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates 131
Immunopathogenesis of Psoriasis: a possible role of TGF/Smads pathway. 130
Staging and follow-up of cutaneous Melanoma patients 127
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten 126
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 126
The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions 125
β-Lactamases as major mechanism of resi stance in Gram-negative bacteria. 124
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 124
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 121
QnrB9 in association with TEM-116 extended-spectrum beta-lactamase in Citrobacter freundii isolated from sewage effluent: first report from Italy 120
Kinetic studies on CphA mutants reveal the role of the P158-P172 loop in activity versus carbapenems 119
VEGFR2 expression is differently modulated by parity and nulliparity in mouse ovary 118
Understanding the molecular genetics of basal cell carcinoma 117
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital 115
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 115
A new metallo-beta-lactamase gene (blaIMP-22) harboured in class 1 integron from Pseudomonas fluorescens 112
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 111
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 111
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients 111
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 110
Telomeres and telomerase in cutaneous squamous cell carcinoma 108
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 108
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 107
Molecular alterations in basal cell carcinoma subtypes 107
Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients 106
Natural D240G Toho1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43 106
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 102
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 101
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 98
Urban wastewater reuse: a pilot plant experience 98
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 97
Basal cell carcinoma and inflammation: role of the Gadd45b gene 97
Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital 96
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 96
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes 95
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 95
Class I Integron-Borne bla(VIM-1) Carbapenemase in a Strain of Enterobacter cloacae Responsible for a Case of Fatal Pneumonia 93
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 93
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 92
Immunopathogenesis of psoriasis: a possible role of TGF/Smads pathway 89
Merkel cell carcinoma: an updated overview of clinico-pathological aspects, molecular genetics and therapy 87
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience 86
Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre experience 85
Long-term efficacy data for daylight-PDT 84
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 83
Familial Melanoma: Diagnostic and Management Implications 83
Trustworthy Machine Learning Predictions to Support Clinical Research and Decisions 81
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis 81
Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis 80
Comparing HISAT and STAR-based pipelines for RNA-Seq Data Analysis: A real experience 80
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 79
First Report from Italy of bla(VIM-1) and bla(TEM-1) Genes in Pseudomonas putida and Acinetobacter baumannii Isolated from Wastewater 79
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 79
Cutaneous melanoma in Birt–Hogg–Dubé syndrome: part of the clinical spectrum? 79
Occurrence of Class 1 and 2 Integrons in Resistant Enterobacteriaceae Collected from a Urban Wastewater Treatment Plant: First Report from Central Italy. 77
MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project 77
"Your Skin Tells You" Campaign for keratinocyte cancers: when individuals' selection makes the difference 76
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study 76
Occurrence of multiple melanomas in a patient with punctate palmoplantar keratoderma type-1A associated to alpha and gamma adaptin binding protein 73
Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial 73
The IL-23/Th17 Pathway In Cutaneous Non Melanoma Skin Cancers 72
Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum 71
Risk factors and diagnosis of advanced cutaneous squamous cell carcinoma 71
T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review 70
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 70
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 70
La medicina di laboratorio: Gli Specialisti di domani 69
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 66
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study 64
Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities 64
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors 61
Editorial: New tools and molecular advances in hyperproliferative skin disorders 60
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 58
Editorial: Molecular Genetics of Cutaneous Melanoma: Current Status and Future Direction 54
Totale 8.089
Categoria #
all - tutte 35.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 0 15 82 23 58 23 82 25
2021/2022392 22 17 61 24 14 7 10 37 34 7 29 130
2022/20231.435 92 107 22 167 106 145 6 110 612 10 42 16
2023/2024433 49 11 38 28 23 128 11 23 0 15 26 81
2024/20251.871 55 39 135 110 252 179 287 147 357 66 135 109
2025/20262.375 175 413 667 444 448 228 0 0 0 0 0 0
Totale 8.089